188RNL-BAM

N/A

Report date: 2025/11/27 17:57:28

Base Information

Drug Name188RNL-BAM
Drug Alias NameRhenium-188 NanoLiposome Biodegradable Alginate Microsphere铼-188可生物降解海藻酸盐微球纳米脂质体
ClassificationRadiation-emitting products > Nuclides > Rhenium > 188ReRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPlus Therapeutics IncUT Health San Antonio
China Registration ClassN/A

Develop Information

Active CompaniesUT Health San AntonioPlus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A